Effect of the herbal EMCOF cough syrup for cough control.

Phase 3

Completed

• Conditions: Health Condition 1: J069- Acute upper respiratory infection,unspecified

• Registration Number: CTRI/2023/09/058036
• Lead Sponsor: Medopharm

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-11-20
• Last Update Posted: 19 December 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1. Patients willing to provide written informed consent to participate in the study

2. Male and Female patient in the age range of 10-65 years.

3. Patients with acute and Chronic,Productive or non-productive cough (Dry cough, Wet cough, Asthmatic cough, Allergic cough, Infective cough, Smokers cough, Sore throat, Hoarse cough, Ratting / Tickling cough) presenting in out patient setting.

4. Patients with a baseline daytime cough symptom score of at least 2.

Exclusion Criteria

1. Female patient who is pregnant or lactating.

2. Patients or with clinically suspected lower respiratory tract infection (e.g. pneumonia tuberculosis)

3. Patients taking any other antitussives, sleeping pills, sedative medications, or herbal cough remedies;

4. Patients currently on any treatments that may influence cough.

5. Patient has history of hepatic or renal insufficiency

6. History of hypersensitivity to any of the test products.

7. Any condition decided as unfit for study by Clinical investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified